Profound Medical Ratios (2018-2026) | PROF

Ratios Dec2018 Jan2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 71.04%72.76%70.34%59.65%70.70%73.18%77.70%66.77%71.80%
EBT Margin (Quarter) -536.92%-353.30%-361.45%465.18%-407.59%-706.97%-155.29%-136.34%-131.68%
EBIT Margin (Quarter) -646.19%-401.54%-353.97%-168.04%-426.02%-624.42%-176.18%-123.29%-150.29%
EBITDA Margin (Quarter) -646.19%-401.54%-353.97%-168.04%-426.02%-624.42%-176.18%-123.29%-150.29%
Operating Margin (Quarter) -646.19%-401.54%-353.97%-168.04%-426.02%-624.42%-176.18%-123.29%-150.29%
Net Margin (Quarter) -540.20%-354.28%-368.41%1,020.64%409.16%-709.86%-157.68%1,287.69%132.15%
FCF Margin (Quarter) -371.53%-318.43%-268.53%-118.39%-316.02%-621.62%-190.04%-109.85%-160.82%
Efficiency
Inventory Average (Quarter) 2.71M3.14M4.47M6.37M7.68M7.46M6.30M7.57M8.35M8.29M8.62M
Assets Average (Quarter) 34.70M31.85M67.09M95.69M75.60M54.19M65.55M55.27M45.99M59.89M75.47M
Invested Capital (Quarter) 0.36M0.98M0.70M0.95M1.38M7.17M0.84M1.74M4.48M4.50M
Asset Utilization Ratio (Quarter) 0.180.220.320.260.25
Leverage & Solvency
Interest Coverage Ratio (Quarter) -52.16-161.83-114.10-74.90-86.69-100.26
Debt Ratio (Quarter) 0.260.260.300.120.210.090.070.090.210.060.12
Times Interest Earned (Quarter) -52.16-161.83-114.10-74.90-86.69-100.26
Valuation
Enterprise Value (Quarter) -23.25M-22.50M-14.56M-83.91M-67.15M-46.52M-26.21M-54.91M-46.43M-35.20M-24.83M-59.72M-50.30M
Return Ratios
Return on Sales (Quarter) -0.05%-0.04%-0.04%0.06%-0.04%-0.07%-0.02%-0.01%-0.01%
Return on Capital Employed (Quarter) -60.33%-85.41%-117.15%-76.66%-58.76%
Return on Invested Capital (Quarter) -2.55%0.03%-0.16%-0.07%-0.08%-0.06%
Return on Assets (Quarter) 0.00%0.00%0.00%-0.01%-0.01%